NEW YORK, Oct 9 (Reuters) - The U.S. government expects to be able to provide at no cost more than 1 million doses of antibody treatments for COVID-19 similar to the one President Donald Trump ...

LONDON - Initial results from a large study in the U.K. found that an antibody drug reduced death in hospitalized COVID-19 patients who faced the highest risk from the virus. The study was led by the ...

The U.S Food and Drug Administration is authorizing Regeneron's antibody cocktail for some patients who test positive for COVID-19. The FDA said Saturday that it's okay to give it to high-risk ...

The FDA has authorized a new version of Regeneron’s COVID-19 drug that can be given by injection, which should make it easier to give to patients. Regeneron said June 4 the FDA is now allowing the ...

President Donald Trump is now "in a race" against the coronavirus, the CEO of biotechnology company Regeneron said Friday after the drug maker provided a dose of its experimental antibody treatment to ...

(Reuters) - Regeneron Pharmaceuticals Inc on Tuesday said its experimental two-antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients, enhancing its chances ...

Regeneron’s COVID-19 antibody cocktail, casirivimab and imdevimab, reduced the risk of death among hospitalized patients in a phase 3 trial, the drugmaker said June 16. The trial found that adding ...

TARRYTOWN, N.Y. - A COVID-19 antibody cocktail developed by U.S. drugmaker Regeneron offered strong protection against symptomatic infection when given to people living with someone else infected with ...

Among other things, we talked about President Trump’s “most-favored nations” policy on drug pricing and why Regeneron is the ...

The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...

Monoclonal antibodies have been around for decades. Antibody medicines like the one that earned President Donald Trump's praise after treatment earlier this month are not just for COVID-19. For the ...